✦ LIBER ✦

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

✍ Scribed by Stone, G.W; Ellis, S.G; Cox, D.A

Book ID: 123371281
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 32 KB
Volume: 39
Category: Article
ISSN: 1097-6809
DOI: 10.1016/j.jvs.2004.02.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A polymer-based, paclitaxel-eluting sten

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

✍ G.W. Stone; S.G. Ellis; D.A. Cox 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Comparison of a Polymer-Based Paclitaxel

Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease: A Randomized Controlled Trial

✍ G.W. Stone; S.G. Ellis; L. Cannon 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Gender-based Outcomes After Paclitaxel-e

Gender-based Outcomes After Paclitaxel-eluting Stent Implantation in Patients With Coronary Artery Disease

✍ A.J. Lansky; R.A. Costa; M. Mooney 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Gender-based outcomes after paclitaxel-e

Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease

✍ Alexandra J. Lansky; Ricardo A. Costa; Michael Mooney; Mark G. Midei; Henry K. L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Everolimus-Eluting versus Paclitaxel-Elu

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

✍ Stone, Gregg W.; Rizvi, Ali; Newman, William; Mastali, Kourosh; Wang, John C.; C 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 379 KB

Everolimus-Eluting versus Paclitaxel-Elu

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

✍ Stone, Gregg W.; Rizvi, Ali; Newman, William; Mastali, Kourosh; Wang, John C.; C 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 379 KB

## Background: Previous studies have established the superiority of coronary everolimus-eluting stents over paclitaxel-eluting stents with respect to angiographic findings. however, these trials were not powered for superiority in clinical end points. ## Methods: We randomly assigned 3687 patient